Intestinal complications of cystic fibrosis

Current Opinion in Pulmonary Medicine

Volumn 19, Issue 6, 2013, Pages 676-680

  Borowitz, Drucy ^a   Gelfond, Daniel ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

dysbiosis; hepatobiliary problems; intestinal obstruction; meconium ileus; pancreatic function

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOGLIN; LIVER ENZYME; NEW DRUG; PANCREAS ENZYME; PLASMINOGEN ACTIVATOR INHIBITOR 1; SECRETIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ANTIBIOTIC THERAPY; CONTROLLED CLINICAL TRIAL (TOPIC); CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; DIGESTIVE SYSTEM CANCER; DISTAL INTESTINAL OBSTRUCTION SYNDROME; DYSBIOSIS; EOSINOPHILIC ESOPHAGITIS; EXPERIMENTAL MOUSE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HEPATOBILIARY DISEASE; HUMAN; HYPERTRANSAMINASEMIA; INTESTINAL DYSMOTILITY; INTESTINE OBSTRUCTION; LIVER DISEASE; LUNG DISEASE; MECONIUM ILEUS; MEDICAL SPECIALIST; MULTICENTER STUDY (TOPIC); NONHUMAN; PANCREAS INSUFFICIENCY; PANCREAS SECRETION; PANCREATITIS; PATIENT REFERRAL; PHASE 3 CLINICAL TRIAL (TOPIC); PORCINE MODEL; PREVALENCE; RECTUM BIOPSY; REVIEW; SUBSTITUTION THERAPY;

ANIMALS; CYSTIC FIBROSIS; DIGESTIVE SYSTEM DISEASES; DISEASE MODELS, ANIMAL; DYSBIOSIS; GASTROINTESTINAL DISEASES; HUMANS; ILEUS; INTESTINAL OBSTRUCTION; LIVER DISEASES; MECONIUM; MICE; PANCREATIC DISEASES; PROGNOSIS; RECTUM; SWINE;

EID: 84885177027     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283659ef2     Document Type: Review

References (40)

1. Gelfond D, Borowitz D. Gastrointestinal complications of cystic fibrosis. Clin Gastroenterol Hepatol 2013; 11:333-342.
2. Carlyle BE, Borowitz DS, Glick PL. A review of pathophysiology and management of fetuses and neonates with meconium ileus fo. The pediatric surgeon. J Pediatr Surg 2012; 47:772-781.
3. Stoltz DA, Rokhlina T, Ernst SE, et al. Intestinal CFTR expression alleviates meconium ileus in cystic fibrosis pigs. J Clin Invest 2013; 123:2685-2693.
4. Uc A, Giriyappa R, Meyerholz DK, et al. Pancreatic and biliary secretion are both altered in cystic fibrosis pigs. A m J Physiol Gastrointest Liver Physiol 2012; 303:G961-G968.
5. Cystic Fibrosis Foundation. Patient Registry, 2011 Annual Data Report to the Center Directors. Bethesda, MD: Cystic Fibrosis Foundation; 2012.
6. Borowitz D, Stevens C, Brettman LR, et al., Liprotamase 767 Study Group. Liprotamase long-term safety and support of nutritional status in pancreaticinsufficient cystic fibrosis. J Pediatr Gastroenterol Nutr 2012; 54:248-257.
7. O'Sullivan BP, Baker D, Leung KG, et al. Evolution of pancreatic function durin. The first year in infants with cystic fibrosis. J Pediatr 2013; 162:808-812.
8. Ng SM, Francini AJ. Drug therapies for reducing gastric acidity in people with cystic fibrosis. Cochrane Database Syst Rev 2012; 4:CD003424.
9. Palm K, Sawicki G, Rosen R. The impact of reflux burden on Pseudomonas positivity in children with cystic fibrosis. Pediatr Pulmonol 2012; 47:582-587.
10. Pauwels A, Blondeau K, Dupont LJ, Sifrim D. Mechanisms of increased gastroesophageal reflux in patients with cystic fibrosis. Am J Gastroenterol 2012; 107:1346-1353.
11. Pauwels A, Decraene A, Blondeau K, et al. Bile acids in sputum and increased airway inflammation in patients with cystic fibrosis. Chest 2012; 141:1568-1574.
12. Goralski JL, Lercher DM, Davis SD, Dellon ES. Eosinophilic esophagitis in cystic fibrosis\: A case series and review of the literature. J Cyst Fibros 2013; 12:9-14.
13. Ooi CY, Dorfman R, Cipolli M, et al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology 2011; 140:153-161.
14. Bertin C, Pelletier AL, Vullierme MP, et al. Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations. Am J Gastroenterol 2012; 107:311-317.
15. Houwen RH, van der Doef HP, Sermet I, et al. Defining DIOS and constipation in cystic fibrosis with a multicentre study of the incidence, characteristics, and treatment of DIOS. J Pediatr Gastroenterol Nutr 2010; 50:38-42.
16. Colombo C, Ellemunter H, Houwenc R, et al. Guidelines fo. The diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients. J Cyst Fibros 2011; 10 (Suppl 2):S24-S28.
17. Rovner AJ, Schall JI, Mondick JT, et al. Delayed small bowel transit in children with cystic fibrosis and pancreatic insufficiency. J Pediatr Gastroenterol Nutr 2013; 57:81-84.
18. Hedsund C, Gregersen T, Joensson IM, et al. Gastrointestinal transit times and motility in patients with cystic fibrosis. Scand J Gastroenterol 2012; 47:920-926.
19. Gelfond D, Ma C, Semler J, Borowitz D. Intestinal pH and gastrointestinal transit profiles in cystic fibrosis patients measured by wireless motility capsule. Dig Dis Sci 2013; 58:2275-2281.
20. De Lisle RC, Meldi L, Mueller R. Intestinal smooth muscle dysfunction develops postnatally in cystic fibrosis mice. J Pediatr Gastroenterol Nutr 2012; 55:689-694.
21. Risse PA, Kachmar L, Matusovsky OS, et al. Ileal smooth muscle dysfunction and remodeling in cystic fibrosis. Am J Physiol Gastrointest Liver Physiol 2012; 303:G1-G8.
22. Gustafsson JK, Ermund A, Ambort D, et al. Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype. J Exp Med 2012; 209:1263-1272.
23. Madan JC, Koestler DC, Stanton BA, et al. Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. MBio 2012; 3: e00251-12.
24. Duytschaever G, Huys G, Bekaert M, et al. Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota. J Cyst Fibros 2013; 12:206-215.
25. Schippa S, Iebba V, Santangelo F, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients. PLoS One 2013; 8:e61176.
26. Lynch SV, Goldfarb KC, Wild YK, et al. Cystic fibrosis transmembrane conductance regulator knockout mice exhibit aberrant gastrointestinal microbiota. Gut Microbes 2013; 4:41-47.
27. Wouthuyzen-Bakker M, Bijvelds MJ, de Jonge HR, et al. Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis. Pediatr Res 2012; 71:4-12.
28. Maisonneuve P, Marshall BC, Knapp EA, Lowenfels AB. Cancer risk in cystic fibrosis\: A 20-year nationwide study from the United States. J Natl Cancer Inst 2013; 105:122-129.
29. Flass T, Narkewicz MR. Cirrhosis and other liver disease in cystic fibrosis. J Cyst Fibros 2013; 12:116-124.
30. Friedrich-Rust M, Schlueter N, Smaczny C, et al. Noninvasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis. J Cyst Fibros 2013; 12:431-439.
31. Kitson MT, Kemp WW, Iser DM, et al. Utility of transient elastography in the noninvasive evaluation of cystic fibrosis liver disease. Liver Int 2013; 33:698-705.
32. Pereira TN, Lewindon PJ, Greer RM, et al. Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease. J Pediatr Gastroenterol Nutr 2012; 54:328-335.
33. Rath T, Hage L, Kü glerM, et al. Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease. PLoS One 2013; 8:e58955.
34. Vandeleur M, Massie J, Oliver M. Gastrostomy in children with cystic fibrosis and portal hypertension. J Pediatr Gastroenterol Nutr 2013; 57:245-247.
35. Harring TR, Nguyen NT, Liu H, et al. Liver transplantation in cystic fibrosis\: A report from Baylor College of Medicine and the Texas Children's Hospital. Pediatr Transplant 2013; 17:271-277.
36. Desai CS, Gruessner A, Habib S, et al. Survival of cystic fibrosis patients undergoing liver and liver-lung transplantations. Transplant Proc 2013; 45:290-292.
37. Miller MR, Sokol RJ, Narkewicz MR, Sontag MK. Pulmonary function in individuals who underwent liver transplantation: from the US Cystic Fibrosis Foundation registry. Liver Transpl 2012; 18:585-593.
38. Hug MJ, Derichs N, Bronsveld I, Clancy JP. Measurement of ion transport function in rectal biopsies. Methods Mol Biol 2011; 741:87-107.
39. Servidoni MF, Sousa M, Vinagre AM, et al. Rectal forceps biopsy procedure in cystic fibrosis: technical aspects and patients perspective for clinical trials feasibility. BMC Gastroenterol 2013; 13:91.
40. Liu J, Walker NM, Cook MT, et al. Functional Cftr in crypt epithelium of organotypic enteroid cultures from murine small intestine. Am J Physiol Cell Physiol 2012; 302:C1492-C1503.